Hope For Alzheimer’s Disease

Facebook
Google+
http://www.b-tv.com/promis-neuroscience-corporate-video
Twitter
LinkedIn

Alzheimer’s disease results from the progressive death of brain cells or neurons. Over time the loss of neurons affects processing of information leading to increasingly severe memory loss, disorientation, mood and behavior changes. Are we making any progress on finding a cure for Alzheimer’s disease? Yes, because we now know the underlying driver of Alzheimer’s and how to target the root cause. Recent failures in advanced clinical trials by big pharma companies have been disappointing however, results of these trials taught us that to be successful, treatments need to selectively target the toxic form of amyloid beta that kills brain cells. Since this is the primary driver of Alzheimer’s disease. What exactly is this approach? Amyloid Beta exists in three forms. Monomer, Plaque and toxic oligomer. The oligomer, the deadly toxic form and the only one known to kill neurons and slowly spread destruction throughout the brain.The lack of clinical success to date is consistent with the fact that none of the therapeutics tested so far selectively targeted this toxic Oligomer. Using this proprietary discovery platform, ProMIS Neurosciences has developed antibody therapeutics that selectively target this toxic oligomer. In preclinical studies, ProMIS’ products in development blocked the toxicity and spread of these toxic oligomers providing positive results and real hope. ProMIS Neuroscience, on track for an effective treatment for Alzheimer’s disease.

ProMIS™ Neurosciences, Inc., headquartered in Toronto Ontario, and with offices in Cambridge Massachusetts, is publicly traded on the Toronto Stock Exchange (ticker symbol: PMN.TO). As a development stage biotech company ProMIS’ mission is to discover and develop best in class precision therapeutics for treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).

For more information on ProMIS Neurosciences Inc. (PMN.TO) please fill out the form below.

Request Investor Kit

Name*

Email*

Phone Number*

*Required.

Related News

BTVLogo1
Shot on location and broadcast on national TV, BTV takes INVESTORS directly to companies! Now 18 years strong and Canada’s longest running business show, BTV-Business Television, a weekly investor program, features emerging companies and top analysts across the US and Canada. With Host, Taylor Thoen, BTV goes on location, interviewing key executives and showcasing their business to give investors insight and help them grow their portfolio. BTV is broadcast internationally to millions on TV via BNN, US Biz Network and Air Canada and top financial sites including: Bloomberg, Yahoo Finance, TMX Money, BNN.ca, Reuters, Globe Investor, OTC Markets, The National Post, MarketWatch, Stockhouse.com, etc. For upcoming episodes and how to have your company featured contact info@b-tv.com.

Watch BTV
ceo-clips-footer-logo
Meet the CEO before you invest! CEO Clips, Canada’s largest library of publicly traded company videos. Did you know management is one of the top three reasons why investors buy a stock? CEO Clips are 90 second video profiles designed to help investors make an educated buying decision. CEO Clips are broadcast on national TV and distributed on top financial sites including: Bloomberg, Yahoo Finance, TMX Money, BNN.ca, Reuters, Globe Investor, OTC Markets, The National Post, MarketWatch, Stockhouse.com, etc. According to Forbes, 60% of people prefer watching video over reading text. We’ve featured over 2000 companies; what are you waiting for? To produce your CEO Clip, contact info@b-tv.com.

Watch CEO Clips
Broadcast On

© 2018 Business Television All Rights Reserved